|
Lacosamide-13C,D3, 1.0 mg/mL
|
L-032
|
1.0 mg/mL in Acetonitrile
An internal standard suitable for GC/MS or LC/MS applications in lacosamide testing from clinical toxicology and forensic analysis to urine drug testing and isotope dilution methods. Lacosamide is a new antiepileptic drug approved by the FDA in late 2008 for the treatment of partial-onset seizures and diabetic neuropathic pain. The drug is marketed under the trade name Vimpat®.
|
|
|